Special eyewear for cancer surgeons

November 17, 2014

Innovation helps surgeons “see” cancerous cells during surgery


Special eyewear for cancer surgeons

 

Don the eyewear before you pick up the scalpel. That may just be the surgical protocol of the future as high-tech glasses are now helping surgeons to see cancerous cells better during surgery.

The eyewear is being developed by Dr Samuel Achilefu, Professor of Radiology, Biomedical Engineering, Biochemistry, and Molecular Biophysics at Washington University School of Medicine in St. Louis, US. It enhances the visualisation capabilities of surgeons, allowing them to distinguish cancer cells from healthy ones.

A fluorescent marker injected into the patient makes the cancer cells glow blue when they are inspected through the eyewear, which also comes with custom video technology and a head-mounted display.

Seeing things with new eyes makes it less likely that stray cancer cells will be left behind during surgery. Currently surgeons remove healthy tissue around the cancer site together with the tumour, and they check for the presence of cancer cells in a pathology lab. A follow-up surgical procedure is required if these are found in the neighbouring tissue. The new eyewear may help to eliminate the need for additional surgery, as well as the pain, expense, time, and anxiety for the patient that accompany it.

The eyewear was used in the operating theatre at the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine for the first time in February this year. It has since been tested on patients with breast cancer and melanoma as well. Aside from a patent for the technology, Dr Achilefu is currently seeking approval from the US Food and Drug Administration (FDA) for a different molecular agent that can be used with the glasses. This will target cancer cells more specifically and remain in them longer. “Our goal is to make sure no cancer is left behind,” Dr Achilefu said in a press release from the Washington University School of Medicine.

 

Further links:
Wustl.edu
Barnesjewish.org

Related Articles

“Tidal wave” of cancer predicted

WHO predicts doubling of annual cancer cases by year 2034

Read more

What you need to know about 9 most common cancers

Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths are caused by cancer.

Read more

What is prostate cancer?

Parkway Cancer Centre’s Dr Zee Ying Kiat gives the low-down on prostate cancer

Read more

Latest Articles

Medical Care

DIGITAL HEALTH SOLUTION SERVICE PROVIDER OF THE YEAR IN INDONESIA

BitHealth has been honoured as Indonesia’s top digital health provider for 2025, revolutionising healthcare with AI, EMR, HIS, and integrated tech systems. Discover how their solutions are transforming hospitals across the nation.

Read more
Medical Care

IJN PERFORMS MALAYSIA'S FIRST PAEDIATRIC LVAD IMPLANTATION

Institut Jantung Negara has achieved a medical first with the successful implantation of a paediatric LVAD in a young heart failure patient. The life-saving procedure showcases Malaysia’s growing capabilities in advanced cardiac care.

Read more
Health & Wellness

Why Wait? Discover How Filler Injections Can Transform Your Look and Boost Your Confidence Naturally

Discover how non-surgical filler injections can restore facial volume, reduce wrinkles, and enhance your features instantly. Let DoctorJob Clinic help you regain confidence with customised, expert treatments.

Read more
Terms & Conditions Privacy Policy
Copyright © 2015 - 2020. All rights reserved.